Publication | Open Access

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Long CovidTreatment And PreventionCovid-19 PandemicAdverse OutcomesAntiviral TherapyEarly TreatmentCovid-19 EpidemiologyInfection ControlPublic HealthMedicineEpidemiologyCovid-19